Shanghai Rightongene Biotechnology Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shanghai Rightongene Biotechnology Co., Ltd.

Why is Shanghai Rightongene Biotechnology Co., Ltd. ?

Poor Management Efficiency with a low ROCE of 2.56%

The company has been able to generate a Return on Capital Employed (avg) of 2.56% signifying low profitability per unit of total capital (equity and debt)

Poor long term growth as Net Sales has grown by an annual rate of -8.84% and Operating profit at -201.90% over the last 5 years

The company has declared negative results for the last 8 consecutive quarters

INTEREST(9M) At CNY 0.19 MM has Grown at inf%
NET PROFIT(Q) At CNY -9.61 MM has Fallen at -71.62%
ROCE(HY) Lowest at -2.96%

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 30.02%, its profits have fallen by -3421%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Shanghai Rightongene Biotechnology Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Shanghai Rightongene Biotechnology Co., Ltd.

29.23%

0.88

37.43%

China Shanghai Composite

16.01%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-8.84%

EBIT Growth (5y)

-201.90%

EBIT to Interest (avg)

5.90

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.24

Sales to Capital Employed (avg)

0.28

Tax Ratio

8.57%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

2.56%

ROE (avg)

2.44%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.70

EV to EBIT

-31.63

EV to EBITDA

-1338.70

EV to Capital Employed

1.90

EV to Sales

6.39

PEG Ratio

Dividend Yield

ROCE (Latest)

-6.01%

ROE (Latest)

-3.70%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

Mildly Bearish

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company

NET PROFIT(HY)

Higher at CNY -8.87 MM

RAW MATERIAL COST(Y)

Fallen by -16.73% (YoY

-33What is not working for the Company

INTEREST(9M)

At CNY 0.19 MM has Grown at inf%

NET PROFIT(Q)

At CNY -9.61 MM has Fallen at -71.62%

ROCE(HY)

Lowest at -2.96%

PRE-TAX PROFIT(Q)

At CNY -13.59 MM has Fallen at -51%

DEBTORS TURNOVER RATIO(HY)

Lowest at 1.08 times

NET SALES(Q)

Lowest at CNY 34.36 MM

OPERATING PROFIT MARGIN(Q)

Lowest at -40.47 %

Here's what is working for Shanghai Rightongene Biotechnology Co., Ltd.

Raw Material Cost

Fallen by -16.73% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Shanghai Rightongene Biotechnology Co., Ltd.

Interest

At CNY 0.19 MM has Grown at inf%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Net Sales

At CNY 34.36 MM has Fallen at -35.26%

over average net sales of the previous four periods of CNY 53.07 MM

MOJO Watch

Near term sales trend is extremely negative

Net Sales (CNY MM)

Net Profit

At CNY -9.61 MM has Fallen at -71.62%

over average net sales of the previous four periods of CNY -5.6 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Pre-Tax Profit

At CNY -13.59 MM has Fallen at -51%

over average net sales of the previous four periods of CNY -9 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Sales

Lowest at CNY 34.36 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Operating Profit Margin

Lowest at -40.47 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Debtors Turnover Ratio

Lowest at 1.08 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio